# Safety and Clinical Applicability of Transcorneal Electrical Stimulation (TES) in Geographic Atrophy

> **NCT07531927** · NA · RECRUITING · sponsor: **Okuvision GmbH** · enrollment: 70 (estimated)

## Conditions studied

- Geographic Atrophy Secondary to Age-related Macular Degeneration

## Interventions

- **DEVICE:** Transcorneal electrical stimulation (TES) with the OkuStim 2 System
- **DEVICE:** Transcorneal electrical stimulation (TES) with the OkuStim 2 System

## Key facts

- **NCT ID:** NCT07531927
- **Lead sponsor:** Okuvision GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-05
- **Primary completion:** 2028-06
- **Final completion:** 2028-06
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-05-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07531927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07531927, "Safety and Clinical Applicability of Transcorneal Electrical Stimulation (TES) in Geographic Atrophy". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07531927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*